Literature DB >> 28407243

Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Chin Jung Cheng1, Heidi Koldsø1,2, Marc W Van der Kamp1, Birgit Schiøtt2, Valerie Daggett1.   

Abstract

Prion diseases are associated with the misfolding of the prion protein (PrP) from its normal cellular form (PrPC ) to its infectious scrapie form (PrPSc ). Post-translational modifications in PrP in vivo can play an important role in modulating the process of misfolding. To gain more insight into the effects of post-translational modifications in PrP structure and dynamics and to test the hypothesis that such modifications can interact with the protein, we have performed molecular dynamics simulations of diglycosylated human PrPC bound to a lipid bilayer via a glycophosphatidylinositol anchor. Multiple simulations were performed at three different pH ranges to explore pH effects on structure and dynamics. In contrast to simulations of protein-only PrPC , no large effects were observed upon lowering the pH of the system. The protein tilted toward the membrane surface in all of the simulations and the putative PrPSc oligomerization sites became inaccessible, thereby offering a possible protective mechanism against PrPSc -induced misfolding of PrPC .
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  membrane simulation; molecular dynamics; prion protein misfolding

Mesh:

Substances:

Year:  2017        PMID: 28407243      PMCID: PMC5500178          DOI: 10.1111/jnc.14044

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  52 in total

1.  Membrane environment alters the conformational structure of the recombinant human prion protein.

Authors:  M Morillas; W Swietnicki; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

2.  The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.

Authors:  Ulrike K Resenberger; Anja Harmeier; Andreas C Woerner; Jessica L Goodman; Veronika Müller; Rajaraman Krishnan; R Martin Vabulas; Hans A Kretzschmar; Susan Lindquist; F Ulrich Hartl; Gerd Multhaup; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2011-03-25       Impact factor: 11.598

3.  Mapping the early steps in the pH-induced conformational conversion of the prion protein.

Authors:  D O Alonso; S J DeArmond; F E Cohen; V Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Glycosylation differences between the normal and pathogenic prion protein isoforms.

Authors:  P M Rudd; T Endo; C Colominas; D Groth; S F Wheeler; D J Harvey; M R Wormald; H Serban; S B Prusiner; A Kobata; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126).

Authors:  Patrick Walsh; Philipp Neudecker; Simon Sharpe
Journal:  J Am Chem Soc       Date:  2010-06-09       Impact factor: 15.419

6.  Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.

Authors:  Wei Chen; Marc W van der Kamp; Valerie Daggett
Journal:  Biochemistry       Date:  2010-10-22       Impact factor: 3.162

Review 7.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

8.  Cell-surface prion protein interacts with glycosaminoglycans.

Authors:  Tao Pan; Boon-Seng Wong; Tong Liu; Ruliang Li; Robert B Petersen; Man-Sun Sy
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Deconvoluting the Cu2+ binding modes of full-length prion protein.

Authors:  Mark Klewpatinond; Paul Davies; Suzanne Bowen; David R Brown; John H Viles
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

10.  The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain.

Authors:  J E Arnold; C Tipler; L Laszlo; J Hope; M Landon; R J Mayer
Journal:  J Pathol       Date:  1995-08       Impact factor: 7.996

View more
  5 in total

1.  Characterization of Lipid-Protein Interactions and Lipid-Mediated Modulation of Membrane Protein Function through Molecular Simulation.

Authors:  Melanie P Muller; Tao Jiang; Chang Sun; Muyun Lihan; Shashank Pant; Paween Mahinthichaichan; Anda Trifan; Emad Tajkhorshid
Journal:  Chem Rev       Date:  2019-04-12       Impact factor: 60.622

Review 2.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

3.  Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity.

Authors:  Chuan-Wei Yi; Li-Qiang Wang; Jun-Jie Huang; Kai Pan; Jie Chen; Yi Liang
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

4.  Atomic insights into the effects of pathological mutants through the disruption of hydrophobic core in the prion protein.

Authors:  Juhwan Lee; Iksoo Chang; Wookyung Yu
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

5.  Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Mohsin Shafiq; Karl Frontzek; Julia Bär; Amulya N Shrivastava; Markus Damme; Feizhi Song; Alexander Schwarz; Stefano Da Vela; Tania Massignan; Sebastian Jung; Angela Correia; Matthias Schmitz; Berta Puig; Simone Hornemann; Inga Zerr; Jörg Tatzelt; Emiliano Biasini; Paul Saftig; Michaela Schweizer; Dmitri Svergun; Ladan Amin; Federica Mazzola; Luca Varani; Simrika Thapa; Sabine Gilch; Hermann Schätzl; David A Harris; Antoine Triller; Marina Mikhaylova; Adriano Aguzzi; Hermann C Altmeppen; Markus Glatzel
Journal:  Sci Adv       Date:  2021-11-24       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.